Corbus Pharmaceuticals Holdings, Inc. CRBP
3.52 USD -0.05 (-1.40%)
Nov 5, 2026, 9:30 AM EST
Day range unavailable
3.57 52-week range 12.88
- YTD
- -56.76%
- 1 year
- -68.71%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 56.78 +1513.0% upside
Now 3.52
- Target (low)
- 35.00
- Target (mean)
- 56.78
- Target (high)
- 75.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
- Strong buy3
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.26 | -1.52 – -1.02 | -1.81 | +30.4% | 0 | 0.0% | 9 |
| Next quarter | -1.51 | -2.95 – -0.77 | -0.83 | -82.2% | 0 | 0.0% | 5 |
| Current year | -4.38 | -5.87 – -3.96 | -10.31 | +57.5% | 0 | 0.0% | 9 |
| Next year | -5.73 | -13.59 – -3.36 | -4.38 | -30.8% | 1.25M | 0.0% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | Piper Sandler | Initiated | — | Overweight |
| Aug 7, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 7, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 10, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 26, 2024 | B. Riley Securities | Initiated | — | Buy |
| Jun 11, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 3, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 13, 2024 | RBC Capital | Initiated | — | Outperform |
| May 8, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 13, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 6, 2024 | Jefferies | Upgrade | Hold | Buy |
| Jan 29, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 9, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 10, 2023 | Oppenheimer | Upgrade | Perform | Outperform |
| Mar 8, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |